PPARG and metabolic dysfunction-associated steatotic liver disease: Inflammatory cytokines, such as TNF-α, IL-6, and IL-8, are involved in the second hit stage, mediate steatohepatitis in patients with NAFLD [7], and can be regulated by PPARγ, which is not only related to anti-inflammatory effects, but also close to improving insulin resistance [8].